Skip to content
mRNAVaccine

The Risks of Trump’s Turn Against mRNA Vaccines

Researchers warn the U.S. could lose its biosecurity edge to China.
Grayson Logue /
Illustration by Noah Hickey (Photos via Unsplash).

More than four years ago, President Donald Trump heralded the arrival of safe and effective messenger RNA (mRNA) vaccines for COVID-19. He called them “a monumental national achievement” and “one of the greatest miracles in the history of modern-day medicine.” 

The mRNA platform enabled scientists to begin work on a vaccine within days of the publication of COVID-19’s genetic sequence.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Grayson Logue is a staff writer for The Dispatch and is based in Philadelphia, Pennsylvania. Prior to joining the company in 2023, he worked in political risk consulting, helping advise Fortune 50 companies. He was also an assistant editor at Providence Magazine and is a graduate student at the University of Edinburgh, pursuing a Master’s degree in history. When Grayson is not writing pieces for the website, he is probably working hard to reduce the number of balls he loses on the golf course.

More We Think You’d Like

Loading